[ET Net News Agency, 24 March 2021] Alphamab Oncology (09966) said its loss was
RMB427.77 million for the year ended 31 December 2020, compared to the loss of RMB832.74
million of the same period last year. No dividend will be distributed.
The other income was RMB111.14 million, a year-on-year increase of 222.8%. (RC)